Europe
The round was led by new investor Abingworth with participation from another new investor, 5AM Ventures, LSP and Versant Ventures.
Here are some tips for getting in the door at one of the top international pharmas in the world.
Strong balance sheet with $235.4 million of cash as of September 30, 2017 supports Company’s current clinical development plans and business development activities.
The company secured a deal to equip Rigshospitalet and Herlev Hospital with modern treatment systems over the next few years.
Another top executive at Glaxo is leaving the company as new CEO Emma Walmsley continues to shape the c-suite for her administration.
Novartis announced they have expanded their collaboration with the Banner Alzheimer’s Institute to launch a new clinical trial in ALZ’s.
Here are four players that have the right combination of elements to post an earnings beat this quarter.
For most biopharma sponsors, the crux of their challenge is how to identify an adequate number of evaluable patients to sufficiently power their late phase clinical research.
Shares of Coloplast are down more than 11 percent this morning after the company presented a new long-term financial guidance that includes a decision to give up on improving its EBIT annually.
Despite Brandicourt’s positive spin, investors were displeased as the company’s financial report fell shy of analysts’ expectations.
PRESS RELEASES